Your browser doesn't support javascript.
loading
SGLT2 inhibitors and euglycemic diabetic ketoacidosis.
Yousaf, Zohaib; Ata, Fateen; Khan, Adeel Ahmad; Razok, Almurtada; Akram, Jaweria; Ali, Elrazi Awadelkarim Hamid; Abdalhadi, Ahmed; Danjuma, Mohammed I; Al Mohanadi, Dabia Hamad S H.
Afiliação
  • Yousaf Z; Department of Medicine, Hamad Medical Corporation, PO Box 3050, Doha, Qatar.
  • Ata F; Department of Medicine, Hamad Medical Corporation, PO Box 3050, Doha, Qatar. docfateenata@gmail.com.
  • Khan AA; Department of Medicine, Hamad Medical Corporation, PO Box 3050, Doha, Qatar.
  • Razok A; Department of Medicine, Hamad Medical Corporation, PO Box 3050, Doha, Qatar.
  • Akram J; Department of Medicine, Hamad Medical Corporation, PO Box 3050, Doha, Qatar.
  • Ali EAH; Department of Medicine, Hamad Medical Corporation, PO Box 3050, Doha, Qatar.
  • Abdalhadi A; Department of Medicine, Hamad Medical Corporation, PO Box 3050, Doha, Qatar.
  • Danjuma MI; Department of Medicine, Hamad Medical Corporation, PO Box 3050, Doha, Qatar.
  • Al Mohanadi DHSH; Department of Medicine, Hamad Medical Corporation, PO Box 3050, Doha, Qatar.
Eur J Clin Pharmacol ; 77(9): 1431-1433, 2021 09.
Article em En | MEDLINE | ID: mdl-33687516
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cetoacidose Diabética / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cetoacidose Diabética / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Idioma: En Ano de publicação: 2021 Tipo de documento: Article